190 related articles for article (PubMed ID: 23607858)
1. Immunophenotypic characterization of lymphoid cell infiltrates in vitiligo.
Sanchez-Sosa S; Aguirre-Lombardo M; Jimenez-Brito G; Ruiz-Argüelles A
Clin Exp Immunol; 2013 Aug; 173(2):179-83. PubMed ID: 23607858
[TBL] [Abstract][Full Text] [Related]
2. Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance.
Le Poole IC; van den Wijngaard RM; Westerhof W; Das PK
Am J Pathol; 1996 Apr; 148(4):1219-28. PubMed ID: 8644862
[TBL] [Abstract][Full Text] [Related]
3. CD8+ T cells from vitiligo perilesional margins induce autologous melanocyte apoptosis.
Wu J; Zhou M; Wan Y; Xu A
Mol Med Rep; 2013 Jan; 7(1):237-41. PubMed ID: 23042234
[TBL] [Abstract][Full Text] [Related]
4. Decreased total numbers of peripheral blood lymphocytes with elevated percentages of CD4+CD45RO+ and CD4+CD25+ of T-helper cells in non-segmental vitiligo.
Mahmoud F; Abul H; Haines D; Al-Saleh C; Khajeji M; Whaley K
J Dermatol; 2002 Feb; 29(2):68-73. PubMed ID: 11890298
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric analysis of peripheral blood lymphocytes in patients with vitiligo.
Sheneef A; Ezz-El DR; Mahmoud TM
Egypt J Immunol; 2012; 19(1):31-8. PubMed ID: 23888549
[TBL] [Abstract][Full Text] [Related]
6. First histopathological and immunophenotypic analysis of early dynamic events in a patient with segmental vitiligo associated with halo nevi.
van Geel NA; Mollet IG; De Schepper S; Tjin EP; Vermaelen K; Clark RA; Kupper TS; Luiten RM; Lambert J
Pigment Cell Melanoma Res; 2010 Jun; 23(3):375-84. PubMed ID: 20370855
[TBL] [Abstract][Full Text] [Related]
7. Expansion of vitiligo lesions is associated with reduced epidermal CDw60 expression and increased expression of HLA-DR in perilesional skin.
Le Poole IC; Stennett LS; Bonish BK; Dee L; Robinson JK; Hernandez C; Hann SK; Nickoloff BJ
Br J Dermatol; 2003 Oct; 149(4):739-48. PubMed ID: 14616364
[TBL] [Abstract][Full Text] [Related]
8. HLA-A2 restricted, melanocyte-specific CD8(+) T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA/MART1.
Lang KS; Caroli CC; Muhm A; Wernet D; Moris A; Schittek B; Knauss-Scherwitz E; Stevanovic S; Rammensee HG; Garbe C
J Invest Dermatol; 2001 Jun; 116(6):891-7. PubMed ID: 11407977
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients.
van den Boorn JG; Konijnenberg D; Dellemijn TA; van der Veen JP; Bos JD; Melief CJ; Vyth-Dreese FA; Luiten RM
J Invest Dermatol; 2009 Sep; 129(9):2220-32. PubMed ID: 19242513
[TBL] [Abstract][Full Text] [Related]
10. Mononuclear cell subpopulations and infiltrating lymphocytes in erythema dyschromicum perstans and vitiligo.
Gross A; Tapia FJ; Mosca W; Perez RM; Briceño L; Henriquez JJ; Convit J
Histol Histopathol; 1987 Jul; 2(3):277-83. PubMed ID: 2980730
[TBL] [Abstract][Full Text] [Related]
11. Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes.
Overwijk WW; Lee DS; Surman DR; Irvine KR; Touloukian CE; Chan CC; Carroll MW; Moss B; Rosenberg SA; Restifo NP
Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2982-7. PubMed ID: 10077623
[TBL] [Abstract][Full Text] [Related]
12. Local immune response in skin of generalized vitiligo patients. Destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site.
van den Wijngaard R; Wankowicz-Kalinska A; Le Poole C; Tigges B; Westerhof W; Das P
Lab Invest; 2000 Aug; 80(8):1299-309. PubMed ID: 10950121
[TBL] [Abstract][Full Text] [Related]
13. Lymphocyte imbalance in vitiligo patients indicated by elevated CD4+/CD8+ T-cell ratio.
Pichler R; Sfetsos K; Badics B; Gutenbrunner S; Berg J; Auböck J
Wien Med Wochenschr; 2009; 159(13-14):337-41. PubMed ID: 19652940
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic T lymphocyte reactivity to gp100, MelanA/MART-1, and tyrosinase, in HLA-A2-positive vitiligo patients.
Mandelcorn-Monson RL; Shear NH; Yau E; Sambhara S; Barber BH; Spaner D; DeBenedette MA
J Invest Dermatol; 2003 Sep; 121(3):550-6. PubMed ID: 12925214
[TBL] [Abstract][Full Text] [Related]
15. NKG2D Defines a Subset of Skin Effector Memory CD8 T Cells with Proinflammatory Functions in Vitiligo.
Jacquemin C; Martins C; Lucchese F; Thiolat D; Taieb A; Seneschal J; Boniface K
J Invest Dermatol; 2020 Jun; 140(6):1143-1153.e5. PubMed ID: 31877315
[TBL] [Abstract][Full Text] [Related]
16. Immunopolarization of CD4+ and CD8+ T cells to Type-1-like is associated with melanocyte loss in human vitiligo.
Wańkowicz-Kalińska A; van den Wijngaard RM; Tigges BJ; Westerhof W; Ogg GS; Cerundolo V; Storkus WJ; Das PK
Lab Invest; 2003 May; 83(5):683-95. PubMed ID: 12746478
[TBL] [Abstract][Full Text] [Related]
17. An immunohistological study of cutaneous lymphocytes in vitiligo.
Badri AM; Todd PM; Garioch JJ; Gudgeon JE; Stewart DG; Goudie RB
J Pathol; 1993 Jun; 170(2):149-55. PubMed ID: 8345407
[TBL] [Abstract][Full Text] [Related]
18. Innate lymphocyte-induced CXCR3B-mediated melanocyte apoptosis is a potential initiator of T-cell autoreactivity in vitiligo.
Tulic MK; Cavazza E; Cheli Y; Jacquel A; Luci C; Cardot-Leccia N; Hadhiri-Bzioueche H; Abbe P; Gesson M; Sormani L; Regazzetti C; Beranger GE; Lereverend C; Pons C; Khemis A; Ballotti R; Bertolotto C; Rocchi S; Passeron T
Nat Commun; 2019 May; 10(1):2178. PubMed ID: 31097717
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune vitiligo does not require the ongoing priming of naive CD8 T cells for disease progression or associated protection against melanoma.
Byrne KT; Zhang P; Steinberg SM; Turk MJ
J Immunol; 2014 Feb; 192(4):1433-9. PubMed ID: 24403535
[TBL] [Abstract][Full Text] [Related]
20. Profiles of pulp infiltrating lymphocytes at various times throughout feather regeneration in Smyth line chickens with vitiligo.
Shresta S; Smyth JR; Erf GF
Autoimmunity; 1997; 25(4):193-201. PubMed ID: 9344327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
